HomeNewscompaniesCoronavirus pandemic| Staff shortage leads grocery firms to seek talent elsewhere

Coronavirus pandemic| Staff shortage leads grocery firms to seek talent elsewhere

The entire retail industry (including grocery stores) is seeing a slowdown over the last two weeks. Talent shortage has amplified the problem

April 03, 2020 / 16:14 IST
Story continues below Advertisement
Representative image
Representative image

At a suburban Mumbai grocery chain, customers were finding it tough to buy essentials since almost 60 percent of the store staff was on leave due to the novel coronavirus, or COVID-19, outbreak. Instead of shutting the store, this supermarket chain decided to involve locals from March 25 onwards.

“Neighbourhood residents, including retired bank officials and senior company executives working from home, said they were ready to volunteer at the store. Hence, we permitted this and allowed these volunteers to dedicate three-to-four hours a day at our store,” said the talent manager at the grocery chain.

Story continues below Advertisement

To track all live updates from the coronavirus pandemic, click here

A 21-day lockdown announced by Prime Minister Narendra Modi to contain COVID-19 spread meant that public transport would also be suspended. Even essential services like grocery chains are operating with less than 50 percent staff and shorter opening hours leading to customers rushing to the stores.

While local talent are being taken in on a temporary basis to handle the crowd and also help customers inside the store, companies are also open to hiring workers from other sectors.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show